National Bank of Canada’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $50K | Sell |
|
|||||
|
2024
Q4 | $62.5K | Sell |
|
|||||
|
2024
Q3 | $156K | Buy |
|
|||||
|
2024
Q2 | $103K | Buy |
|
|||||
|
2024
Q1 | $98.7K | Sell |
|
|||||
|
2023
Q4 | $3.03M | Buy |
|
|||||
|
2023
Q3 | $111K | Sell |
|
|||||
|
2023
Q2 | $99.3K | Sell |
|
|||||
|
2023
Q1 | $6.75M | Buy |
|
|||||
|
2022
Q4 | $1.33M | Buy |
|
|||||
|
2022
Q3 | $129K | Sell |
|
|||||
|
2022
Q2 | $126K | Buy |
|
|||||
|
2022
Q1 | $118K | Buy |
|
|||||
|
2021
Q4 | $105K | Buy |
|